State of Alaska Department of Revenue Sells 1,026 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

State of Alaska Department of Revenue lessened its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 3.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 28,280 shares of the company’s stock after selling 1,026 shares during the quarter. State of Alaska Department of Revenue owned about 0.06% of Prestige Consumer Healthcare worth $2,038,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of PBH. GHP Investment Advisors Inc. lifted its position in Prestige Consumer Healthcare by 0.5% during the third quarter. GHP Investment Advisors Inc. now owns 86,989 shares of the company’s stock valued at $6,272,000 after purchasing an additional 449 shares during the last quarter. Boston Trust Walden Corp bought a new stake in shares of Prestige Consumer Healthcare during the 3rd quarter worth $41,785,000. International Assets Investment Management LLC grew its position in Prestige Consumer Healthcare by 7,112.5% in the third quarter. International Assets Investment Management LLC now owns 1,154 shares of the company’s stock worth $83,000 after acquiring an additional 1,138 shares in the last quarter. Private Advisor Group LLC grew its position in Prestige Consumer Healthcare by 15.6% in the third quarter. Private Advisor Group LLC now owns 3,380 shares of the company’s stock worth $244,000 after acquiring an additional 457 shares in the last quarter. Finally, Sequoia Financial Advisors LLC increased its stake in Prestige Consumer Healthcare by 12.9% in the third quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company’s stock valued at $708,000 after acquiring an additional 1,120 shares during the last quarter. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently issued reports on PBH. DA Davidson upped their price objective on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Wednesday, August 28th. Jefferies Financial Group restated a “hold” rating and issued a $76.00 target price (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $94.20.

Prestige Consumer Healthcare Stock Up 0.4 %

PBH opened at $74.05 on Friday. The company has a market cap of $3.67 billion, a P/E ratio of 18.11, a P/E/G ratio of 2.08 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 12 month low of $56.61 and a 12 month high of $75.80. The business’s 50-day moving average price is $72.17 and its 200-day moving average price is $69.56. The company has a current ratio of 3.23, a quick ratio of 1.90 and a debt-to-equity ratio of 0.65.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The firm had revenue of $267.10 million during the quarter, compared to the consensus estimate of $260.54 million. During the same quarter in the previous year, the company posted $1.06 earnings per share. The business’s revenue was down 4.4% on a year-over-year basis. On average, equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.43 EPS for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.